PHARMA
China’s Zongyi Group Invests In US-Based ContraFect Corporation
The Zongyi Group of China has invested US$8.6 million into US-based ContraFect Corporation as part of a US$9.5 million financing.
Merck Opens US$120m Manufacturing Facility In Hangzhou, China
Merck announced the opening of its new US$120 million pharmaceutical manufacturing facility in Hangzhou, China.
PerkinElmer, NCDS To Advance Personalized Medicine In China
PerkinElmer, Inc. has announced a new collaboration with the National Center for Drug Screening to advance personalized medicine and drug profiling in China.
CRO Covance Expands Laboratory In Singapore
Covance Inc. has expanded its central laboratory facility in Singapore to meet current and future growth of drug development in the Asia Pacific region.
Eli Lilly’s Elanco Invests US$100m In China Animal Healthcare
Elanco has announced a US$100 million investment to purchase a minority equity stake in China Animal Healthcare Ltd.
GSK, Eddingpharm To Collaborate On Novel Breast Cancer Drug In China
China's Eddingpharm will launch GSK's new drug for advanced or metastatic breast cancer in China.
Tarafenacin Shows Success In South Korean Overactive Bladder Syndrome Trial
SALVAT and Kwang Dong Pharma have successfully completed a Phase IIb trial for Tarafenacin for the treatment of Overactive Bladder syndrome.
X-BODY, Jiangsu Hengrui To Develop Novel Therapeutic Antibodies
X-BODY Biosciences has signed an agreement with Jiangsu Hengrui to commercialize therapeutic antibodies for age-related macular degeneration.
Sanofi Pasteur, Xiamen University To Develop Universal Flu Vaccine
Sanofi Pasteur and Xiamen University in China have agreed to jointly develop a universal flu vaccine.
